Logo image of SYRE

SPYRE THERAPEUTICS INC (SYRE) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:SYRE - US00773J2024 - Common Stock

33.24 USD
+0.15 (+0.45%)
Last: 1/16/2026, 8:00:01 PM
33.21 USD
-0.03 (-0.09%)
After Hours: 1/16/2026, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
SYRE revenue by date.SYRE revenue by date.
18.74M2.33M
-87.57%
886K
-61.97%
2.142M
-100.00%
12.665M201.98M
1,494.79%
780.85M
286.60%
1.689B
116.30%
EBITDA
YoY % growth
SYRE ebitda by date.SYRE ebitda by date.
-64.07M
20.39%
-83.21M
-29.87%
-116.26M
-39.72%
-193.248M
-79.77%
-217.087M
-3.87%
-258.081M
-18.88%
-253.656M
1.71%
-302.521M
-19.26%
-342.674M
-13.27%
N/AN/AN/AN/A
EBIT
YoY % growth
SYRE ebit by date.SYRE ebit by date.
-65.65M
19.43%
-84.78M
-29.14%
-117M
-38.00%
-205.549M
-78.63%
-214.016M
-2.40%
-269.407M
-25.88%
-311.125M
-15.49%
-333.156M
-7.08%
-394.792M
-18.50%
-474.16M
-20.10%
-398.693M
15.92%
112.61M
128.24%
1.084B
862.61%
Operating Margin
SYRE operating margin by date.SYRE operating margin by date.
-350.32%-3,638.63%-13,205.42%-9,596.12%N/AN/AN/AN/AN/A-3,743.86%-197.39%14.42%64.18%
EPS
YoY % growth
SYRE eps by date.SYRE eps by date.
-25.00
37.89%
-25.25
-1.00%
-59.89
-137.19%
-4.45
92.94%
-2.14
49.39%
-2.74
-27.89%
-2.94
-7.56%
-3.09
-4.98%
-3.48
-12.62%
-3.83
-10.09%
-2.79
27.09%
2.53
190.63%
11.48
353.03%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.79
2.95%
-0.63
-4.31%
-0.65
16.02%
-0.67
-344.19%
-0.69
12.48%
-0.27
57.30%
-0.30
53.63%
-0.32
52.54%
-0.33
51.82%
Revenue
Q2Q % growth
N/AN/AN/AN/A
EBITDA
Q2Q % growth
-60.763M
0.39%
-58.531M-58.47M-60.694M
-8.38%
-62.832M
-3.40%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-62.064M
-1.74%
-62.303M
-15.38%
-63.95M
-22.98%
-66.365M
-16.43%
-70.516M
-13.62%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.15
88.97%
-0.760.6180.30%
Q2 2025
Q2Q % growth
-0.77
10.47%
-0.770.00-0.17%
Q1 2025
Q2Q % growth
-0.60
50.00%
-0.860.2630.06%
Q4 2024
Q2Q % growth
-0.81
80.00%
-1.010.2020.11%
Q3 2024
Q2Q % growth
-1.36
85.44%
-0.84-0.52-61.73%
Q2 2024
Q2Q % growth
-0.86
97.93%
-0.970.1111.25%
Q1 2024
Q2Q % growth
-1.20
76.00%
-1.19-0.01-0.84%
Q4 2023
Q2Q % growth
-4.05
10.00%
-0.80-3.25-406.27%
Q3 2023
Q2Q % growth
-9.34
-96.63%
-0.86-8.48-983.65%
Q2 2023
Q2Q % growth
-41.50
-514.81%
-4.59-36.91-804.14%
Q1 2023
Q2Q % growth
-5.00
45.95%
-4.59-0.41-8.93%
Q4 2022
Q2Q % growth
-4.50
41.94%
-5.100.6011.76%
Q3 2022
Q2Q % growth
-4.75
38.71%
-5.921.1719.71%
Q2 2022
Q2Q % growth
-6.75
-170.00%
-7.951.2015.07%
Q1 2022
Q2Q % growth
-9.25
-32.14%
-8.59-0.66-7.75%
Q4 2021
Q2Q % growth
-7.75
11.43%
-7.29-0.46-6.37%
Q3 2021
Q2Q % growth
-7.75
-6.90%
-7.10-0.65-9.10%
Q2 2021
Q2Q % growth
-2.50
75.00%
-4.191.6940.33%
Q1 2021
Q2Q % growth
-7.00
50.88%
-4.34-2.67-61.48%
Q4 2020
Q2Q % growth
-8.75 -7.86-0.89-11.29%
Q3 2020
Q2Q % growth
-7.25 -9.982.7327.37%
Q2 2020
Q2Q % growth
-10.00 -11.261.2611.16%
Q1 2020
Q2Q % growth
-14.25 -16.702.4514.68%
SYRE Yearly EPS VS EstimatesSYRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -50 -100 -150 -200
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
2.142M-2.142M-100.00%
Q2 2024
Q2Q % growth

-100.00%
4.08M-4.08M-100.00%
Q1 2024
Q2Q % growth

-100.00%
%
Q4 2023
Q2Q % growth

-100.00%
224.4K-224.4K-100.00%
Q3 2023
Q2Q % growth

-100.00%
%
Q2 2023
Q2Q % growth
688K
9.21%
688K%
Q1 2023
Q2Q % growth
198K
-85.44%
125.123K72.877K58.24%
Q4 2022
Q2Q % growth
170K
-95.33%
59.16K110.84K187.36%
Q3 2022
Q2Q % growth
170K
-87.86%
212.497K-42.497K-20.00%
Q2 2022
Q2Q % growth
630K
-95.40%
578.952K51.048K8.82%
Q1 2022
Q2Q % growth
1.36M 1.346M14K1.04%
Q4 2021
Q2Q % growth
3.64M 3.13M510K16.29%
Q3 2021
Q2Q % growth
1.4M 4.131M-2.731M-66.11%
Q2 2021
Q2Q % growth
13.7M 12.393M1.307M10.55%
Q1 2021
Q2Q % growth
13.26M-13.26M-100.00%
SYRE Yearly Revenue VS EstimatesSYRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2021 2022 2023 2024 2030 2031 2032 2033 500M 1B 1.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS1.42% 6.73% 1.92% 27.02%
RevenueN/A N/A N/A N/A